PharmaVoice Logo

Healthcare Leaders Hub

Sponsored content

Featured promotional

Jeplus.in
Sponsored

Jeplus.in

Purchase All Medicines.Get 10% Offer

News

Latest stories

ET Pharma

Nov 2, 2026, 2:27 AM

India’s medicine sales grow in double digits for four straight quarters, led by chronic care drugs

The Central Drugs Standard Control Organization (CDSCO) ordered the shutdown of several hundred non-compliant small and medium-scale units over the last two years, and their sales may have shifted to larger players, industry experts explained, noting that PharmaTrac, a prescription sales tracking agency, does not audit small and medium units.

ET Pharma

Nov 2, 2026, 12:54 AM

Granules’ Gagillapur facility gets 11 observations from FDA

The flagged observations pointed to gaps in investigation procedures, change control, process and equipment qualification, visual-inspection controls and documentation practices.

ET Pharma

Nov 1, 2026, 5:46 AM

Court drops CBI bribery charges against ex-drug controller, 3 others

In June 2022, the CBI registered a case against Dr Eswara Reddy for manipulating the SEC review of three product approval files, However the Rouse Avenue District Court observed that the prosecution had ā€œfailed to establish even a prima facie case for the offences alleged in the charge sheet

Express Pharma

Nov 1, 2026, 5:39 AM

Express Pharma November 2026

India's Foremost Pharma & Biotech Magazine ~ PLI 2.0: Can MSMEs Catch Up? The post Express Pharma November 2026 appeared first on Express Pharma.

ET Pharma

Oct 31, 2026, 8:37 AM

AstraZeneca kicks off $1.5 billion savings drive to invest in drug pipeline

⁠On a press call, executives said some departments face cutbacks or restructuring, while others will re-skill and hire for emerging needs. Soriot said shifting ​focus from patent-expiring drugs such as Farxiga and Brilinta to oncology and rare diseases could render some R&D roles redundant.

ET Pharma

Oct 30, 2026, 11:28 PM

Sun Pharma terms recalled eye drugs production halt a ā€˜voluntary call’

Speaking to analysts, Kirti Ganorkar MD, Sun Pharma said, "there are 11 ophthalmology products which we have voluntarily recalled. We voluntarily initiated a temporary cessation of our manufacturing activities, and we have kept the Indian regulator informed about it.ā€

News

Latest industry coverage

Google News

Nov 2, 2026, 7:49 AM

Alliance Releases Vietnam Biotech Supply Chain Report Following DHS Update - EIN Presswire

Alliance Releases Vietnam Biotech Supply Chain Report Following DHS UpdateĀ Ā EIN Presswire

Google News

Nov 2, 2026, 7:44 AM

Zydus Lifesciences completes acquisition of Sterling Biotech API business - scanx.trade

Zydus Lifesciences completes acquisition of Sterling Biotech API businessĀ Ā scanx.trade

Google News

Nov 2, 2026, 7:20 AM

Sun Pharma Q2 FY27: India Sales Up 17%, US Slips 8% - eHealth Magazine

Sun Pharma Q2 FY27: India Sales Up 17%, US Slips 8%Ā Ā eHealth Magazine

Google News

Nov 2, 2026, 7:14 AM

Yongin Approves HL Genomics Industrial Complex, 27.5 Billion Won to Expand Active Pharmaceutical Ingredient Production Facilities - ģ•„ģ‹œģ•„ź²½ģ œ

Yongin Approves HL Genomics Industrial Complex, 27.5 Billion Won to Expand Active Pharmaceutical Ingredient Production FacilitiesĀ Ā ģ•„ģ‹œģ•„ź²½ģ œ

Google News

Nov 2, 2026, 7:10 AM

Ten traditional pharmaceutical companies tagged with 'low PBR'… corporate valuation improvement emerges as a key challenge - ėØøė‹ˆķˆ¬ė°ģ“

Ten traditional pharmaceutical companies tagged with 'low PBR'… corporate valuation improvement emerges as a key challengeĀ Ā ėØøė‹ˆķˆ¬ė°ģ“

Google News

Nov 2, 2026, 7:07 AM

Drugmakers rush to pair up with Summit’s ivonescimab ahead of key verdict - BioSpace

Drugmakers rush to pair up with Summit’s ivonescimab ahead of key verdictĀ Ā BioSpace

Google News

Nov 2, 2026, 6:46 AM

AstraZeneca Pharma India secures respite in Rs. 151,19,66,035 overcharging case - Business Upturn

AstraZeneca Pharma India secures respite in Rs. 151,19,66,035 overcharging caseĀ Ā Business Upturn

Google News

Nov 2, 2026, 6:43 AM

GENFIT to Highlight Progress in ACLF and MASH Diagnostics at AASLD The Liver MeetingĀ® 2026 - The Manila Times

GENFIT to Highlight Progress in ACLF and MASH Diagnostics at AASLD The Liver MeetingĀ® 2026Ā Ā The Manila Times

Google News

Nov 2, 2026, 6:42 AM

Buy Sun Pharmaceutical Industries; target of Rs 2150: Prabhudas Lilladher - TradingView

Buy Sun Pharmaceutical Industries; target of Rs 2150: Prabhudas LilladherĀ Ā TradingView

Sponsored placement

Featured promotions

Jeplus.in
Sponsored

Jeplus.in

Purchase All Medicines.Get 10% Offer